31st Mar 2008 17:00
AstraZeneca PLC31 March 2008 Transaction by Persons Discharging Managerial ResponsibilitiesDisclosure Rules DR 3.1.4R We hereby inform you that on 28 March 2008, the following individuals, who areall persons discharging managerial responsibilities, were each granted an awardunder the terms of the AstraZeneca Performance Share Plan over the Company'sUSD0.25 Ordinary Shares or, in the case of D Mott, L Tetrault and A Zook, overthe Company's American Depositary Shares (ADSs). One ADS equals one OrdinaryShare Target number of shares Award price per share Normal vesting dateName of individual awarded B Angelici 37,221 1882p 28 March 2011 J Lundberg 36,334 1882p 28 March 2011 D Mott 53,593 US$37.76 28 March 2011 D Smith 27,098 1882p 28 March 2011 L Tetrault 50,477 US$37.76 28 March 2011 A Zook 72,728 US$37.76 28 March 2011 The AstraZeneca Performance Share Plan was approved by shareholders at theCompany's AGM in 2005. Awards made under the Plan may not generally vest beforethe third anniversary of the relevant date of grant nor unless the specifiedperformance target(s) have been met at the end of the three year period which,for this award, is 1 January 2008 to 31 December 2010. With the exception of D Mott, the performance target that applies to this awardis the Company's Total Shareholder Return ("TSR") compared to the TSR of aselected peer group of 12 other pharmaceutical companies. The actual number ofshares to which a participant may become unconditionally entitled will depend onthe extent to which the performance target(s) have been met. A summary of thePlan, including a more detailed explanation of the performance target(s), can befound in the AstraZeneca Annual Report and Form 20-F Information 2007 which isavailable on the Company's website www.astrazeneca.com. For the award granted to D Mott, the performance condition relates to a range offinancial and other business measures in respect of the MedImmune businessmeasured over a three-year performance period. G H R MuskerCompany Secretary31 March 2008 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca